CD4 and neoplasm: This is in agreement with the proposed model suggesting that the expansion and tumor-targeting capacity of human cytotoxic T lymphocytes (CTLs) can be enhanced by CD4+ T-helper cells through costimulatory signals transmitted via surface molecules on the cells, leading to increased proliferation and viability of the CTLs during the effector stage of anti-tumor immune responses [38].